Immunological responses in SARS-CoV-2 and HIV co-infection versus SARS-CoV-2 mono-infection: case report of the interplay between SARS-CoV-2 and HIV.

IF 2.6 4区 医学 Q2 ALLERGY
Shima Shahbaz, Wendy Sligl, Mohammed Osman, Shokrollah Elahi
{"title":"Immunological responses in SARS-CoV-2 and HIV co-infection versus SARS-CoV-2 mono-infection: case report of the interplay between SARS-CoV-2 and HIV.","authors":"Shima Shahbaz, Wendy Sligl, Mohammed Osman, Shokrollah Elahi","doi":"10.1186/s13223-023-00846-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>There is an urgent need to understand the interplay between SARS-CoV-2 and HIV to inform risk-mitigation approaches for HIV-infected individuals.</p><p><strong>Objectives: </strong>We conclude that people living with HIV (PLWH) who are antiretroviral therapy (ART) naïve could be at a greater risk of morbidity or mortality once co-infected with SARS-CoV-2.</p><p><strong>Methods: </strong>Here, we performed extensive immune phenotyping using flow cytometry. Moreover, to compare the range of values observed in the co-infected case, we have included a larger number of mono-infected cases with SARS-CoV-2. We also quantified soluble co-inhibitory/co-stimulatory molecules in the plasma of our patients.</p><p><strong>Results: </strong>We noted a robust immune activation characterized by the expansion of CD8<sup>+</sup> T cells expressing co-inhibitory/stimulatory molecules (e.g. PD-1, TIM-3, 2B4, TIGIT, CD39, and ICOS) and activation markers (CD38, CD71, and HLA-DR) in the co-infected case. We further found that neutrophilia was more pronounced at the expense of lymphopenia in the co-infected case. In particular, naïve and central memory CD8<sup>+</sup> T cells were scarce as a result of switching to effector and effector memory in the co-infected case. CD8<sup>+</sup> T cell effector functions such as cytokine production (e.g. TNF-α and IFN-γ) and cytolytic molecules expression (granzyme B and perforin) following anti-CD3/CD28 or the Spike peptide pool stimulation were more prominent in the co-infected case versus the mono-infected case. We also observed that SARS-CoV-2 alters T cell exhaustion commonly observed in PLWH.</p><p><strong>Conclusion: </strong>These findings imply that inadequate immune reconstitution and/or lack of access to ART could dysregulate immune response against SARS-CoV-2 infection, which can result in poor clinical outcomes in PLWH. Our study has implications for prioritizing PLWH in the vaccination program/access to ART in resource-constrained settings.</p>","PeriodicalId":51302,"journal":{"name":"Allergy Asthma and Clinical Immunology","volume":"19 1","pages":"91"},"PeriodicalIF":2.6000,"publicationDate":"2023-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583436/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergy Asthma and Clinical Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13223-023-00846-8","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: There is an urgent need to understand the interplay between SARS-CoV-2 and HIV to inform risk-mitigation approaches for HIV-infected individuals.

Objectives: We conclude that people living with HIV (PLWH) who are antiretroviral therapy (ART) naïve could be at a greater risk of morbidity or mortality once co-infected with SARS-CoV-2.

Methods: Here, we performed extensive immune phenotyping using flow cytometry. Moreover, to compare the range of values observed in the co-infected case, we have included a larger number of mono-infected cases with SARS-CoV-2. We also quantified soluble co-inhibitory/co-stimulatory molecules in the plasma of our patients.

Results: We noted a robust immune activation characterized by the expansion of CD8+ T cells expressing co-inhibitory/stimulatory molecules (e.g. PD-1, TIM-3, 2B4, TIGIT, CD39, and ICOS) and activation markers (CD38, CD71, and HLA-DR) in the co-infected case. We further found that neutrophilia was more pronounced at the expense of lymphopenia in the co-infected case. In particular, naïve and central memory CD8+ T cells were scarce as a result of switching to effector and effector memory in the co-infected case. CD8+ T cell effector functions such as cytokine production (e.g. TNF-α and IFN-γ) and cytolytic molecules expression (granzyme B and perforin) following anti-CD3/CD28 or the Spike peptide pool stimulation were more prominent in the co-infected case versus the mono-infected case. We also observed that SARS-CoV-2 alters T cell exhaustion commonly observed in PLWH.

Conclusion: These findings imply that inadequate immune reconstitution and/or lack of access to ART could dysregulate immune response against SARS-CoV-2 infection, which can result in poor clinical outcomes in PLWH. Our study has implications for prioritizing PLWH in the vaccination program/access to ART in resource-constrained settings.

Abstract Image

Abstract Image

Abstract Image

严重急性呼吸系统综合征冠状病毒2型和艾滋病毒联合感染与严重急性呼吸系冠状病毒2型单一感染的免疫反应:严重急性呼吸综合征冠状病毒-2型和艾滋病毒相互作用的病例报告。
背景:迫切需要了解严重急性呼吸系统综合征冠状病毒2型和艾滋病毒之间的相互作用,为艾滋病毒感染者的风险缓解方法提供信息。目的:我们得出的结论是,接受抗逆转录病毒疗法(ART)的HIV感染者一旦共同感染严重急性呼吸系统综合征冠状病毒2型,发病或死亡的风险可能更大。方法:在这里,我们使用流式细胞术进行了广泛的免疫表型分析。此外,为了比较在共同感染病例中观察到的数值范围,我们纳入了大量严重急性呼吸系统综合征冠状病毒2型的单感染病例。我们还定量了患者血浆中的可溶性共抑制/共刺激分子。结果:我们注意到,在共感染病例中,CD8+T细胞扩增,表达共抑制/刺激分子(如PD-1、TIM-3、2B4、TIGIT、CD39和ICOS)和激活标记物(CD38、CD71和HLA-DR),这是一种强大的免疫激活。我们进一步发现,在合并感染的病例中,中性粒细胞增多症以淋巴细胞减少症为代价更为明显。特别是,在共同感染的病例中,由于转换为效应器和效应器记忆,幼稚和中枢记忆CD8+T细胞稀少。CD8+T细胞效应功能,如抗CD3/CD28或刺突肽库刺激后的细胞因子产生(如TNF-α和IFN-γ)和细胞溶解分子表达(颗粒酶B和穿孔素),在共同感染病例中比单感染病例更突出。我们还观察到,严重急性呼吸系统综合征冠状病毒2型改变了PLWH中常见的T细胞耗竭。结论:这些发现表明,免疫重建不足和/或缺乏抗逆转录病毒疗法可能会失调对严重急性呼吸系统冠状病毒2型感染的免疫反应,这可能导致PLWH的临床结果不佳。我们的研究对在疫苗接种计划中优先考虑PLWH/在资源受限的环境中获得ART具有启示。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.30
自引率
3.70%
发文量
96
审稿时长
12 weeks
期刊介绍: Allergy, Asthma & Clinical Immunology (AACI), the official journal of the Canadian Society of Allergy and Clinical Immunology (CSACI), is an open access journal that encompasses all aspects of diagnosis, epidemiology, prevention and treatment of allergic and immunologic disease. By offering a high-visibility forum for new insights and discussions, AACI provides a platform for the dissemination of allergy and clinical immunology research and reviews amongst allergists, pulmonologists, immunologists and other physicians, healthcare workers, medical students and the public worldwide. AACI reports on basic research and clinically applied studies in the following areas and other related topics: asthma and occupational lung disease, rhinoconjunctivitis and rhinosinusitis, drug hypersensitivity, allergic skin diseases, urticaria and angioedema, venom hypersensitivity, anaphylaxis and food allergy, immunotherapy, immune modulators and biologics, immune deficiency and autoimmunity, T cell and B cell functions, regulatory T cells, natural killer cells, mast cell and eosinophil functions, complement abnormalities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信